BLT Share Price Performance
NZ$0
-0.02 (-100.00%)
Price NZ$0
Share Pricen/a
There's Reason For Concern Over BLIS Technologies Limited's (NZSE:BLT) Price
Dec 03
BLIS Technologies Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
BLT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
BLIS Technologies Limited Key Details
About BLT
- Founded
- 2000
- Employees
- 38
- CEO
- WebsiteView website
BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America. The company offers BLIS K12, an oral probiotic supplement to support ear, nose, and throat health, as well as for enhancing immunity and bad breath; BLIS M18, an oral probiotic to support teeth and gums health; and BLIS Q24, a probiotic supplement to balance the skin microbiome, restoring the health, clarity, and radiance. It provides its products in the ENT, immune, dental, and skin areas. BLIS Technologies Limited was incorporated in 2000 and is based in Dunedin, New Zealand.